Crossmark

An allosteric inhibitor of <i>Mycobacterium tuberculosis</i> ArgJ: Implications to a novel combinatorial therapy

Crossref DOI link: https://doi.org/10.15252/emmm.201708038

Published Online: 2018-02-26

Published Print: 2018-04

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Mishra, Archita https://orcid.org/0000-0003-4381-5990
Mamidi, Ashalatha S

Rajmani, Raju S

Ray, Ananya

Roy, Rajanya

Surolia, Avadhesha https://orcid.org/0000-0002-2466-2514
Funding

Funding for this research was provided by:

Department of Science and Technology, Government of Kerala (DSTO/BMB/ASA/1489)

Indian Council of Medical Research (5/8/5/6/2012‐ECD‐I)

Department of Biotechnology, Government of West Bengal (BT/PR24443/MED/29/1220/2017)
License Information

Version of Record valid from 2018-02-26
More Information

Publication History

Received: 2017-05-16

Accepted: 2018-01-26

Published: 2018-02-26